Copyright 2009 Medical News Today Latest Vascular News From Medical News Today. http://www.medicalnewstoday.com/sections/vascular/ admin@medicalnewstoday.com (MNT Admin) editors@medicalnewstoday.com (MNT Editors) en-us Wed, 25 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/171987.php http://www.medicalnewstoday.com/articles/171987.php When people have malaria, they are infected with Plasmodium parasites, which enter the body from the saliva of a mosquito, infect cells in the liver, and then spread to red blood cells. Inside the blood cells, the parasites replicate and also begin to expose adhesive proteins on the cell surface that change the physical nature of the cells in the bloodstream. Tropical Diseases Mon, 23 Nov 2009 08:00:00 PST http://www.medicalnewstoday.com/articles/171874.php http://www.medicalnewstoday.com/articles/171874.php Atrium Medical Corporation announced that the 100th patient was enrolled in the iCAST™ Atrium Registry Ultrasound Study (iCARUS). The iCARUS study is a prospective, multi-center clinical trial studying the safety and efficacy of the Atrium iCAST™ Balloon Expandable Covered Stent in patients with occlusive disease in the iliac artery. This first of its kind premounted "balloon expandable covered stent" US trial is approved by the FDA under an investigational device exemption. Vascular Sat, 21 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/171779.php http://www.medicalnewstoday.com/articles/171779.php Findings from the Phase III EINSTEIN-Extension study will be presented in the Late Breaking Abstract Session on December 8, 2009, (7:30 am EST, Hall F, Ernest N. Morial Convention Center) at the 51st Annual Meeting of the American Society of Hematology (ASH) in New Orleans, Louisiana. Vascular Thu, 19 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171516.php http://www.medicalnewstoday.com/articles/171516.php Toddlers and obese children suffer more than other youth when exposed to secondhand smoke, according to research presented at the American Heart Association's Scientific Sessions 2009. "Secondhand smoke in children is not just bad for respiratory issues, as has been previously described by other researchers," said John Anthony Bauer, Ph.D. Smoking / Quit Smoking Thu, 19 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171450.php http://www.medicalnewstoday.com/articles/171450.php Endologix, Inc. Vascular Thu, 19 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/171416.php http://www.medicalnewstoday.com/articles/171416.php The routine prescription of extended-release niacin, a B vitamin (1,500 milligrams daily), in combination with traditional cholesterol-lowering therapy offers no extra benefit in correcting arterial narrowing and diminishing plaque buildup in seniors who already have coronary artery disease, a new vascular imaging study from Johns Hopkins experts shows. Statins Thu, 19 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/171391.php http://www.medicalnewstoday.com/articles/171391.php New education strategies for better controlling hypertension and research suggesting a possible link between short-term and long-term exposure to air pollution and increased risk of constricted blood vessels are among the research highlights from studies supported by the National Heart, Lung, and Blood Institute (NHLBI) at the American Heart Association's 2009 Scientific Sessions in Orlando held Nov. 14-18. Cardiovascular / Cardiology Wed, 18 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171316.php http://www.medicalnewstoday.com/articles/171316.php A new study finds that atherosclerosis, hardening of the arteries, was common in ancient Egyptians, challenging a belief that vascular disease is a modern affliction caused by current-day risk factors such as stress and sedentary lifestyles. Michael Miyamoto, MD, a graduate of the UC San Diego School of Medicine and assistant clinical professor, recently returned to the US following an expedition to Egypt to evaluate the prevalence of cardiovascular disease in 3,500-year-old mummies. Heart Disease Wed, 18 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/171350.php http://www.medicalnewstoday.com/articles/171350.php Research into the controversial drug thalidomide reveals that the mechanism through which the drug causes limb defects is the same process which causes it to damage internal organs and other tissues. The article, published in Bio-Essays, outlines the challenges surrounding thalidomide research and claims that confirmation of a 'common mechanism' could lead to new treatments for Leprosy, Crohn's Disease, AIDS and some forms of cancer. Vascular Wed, 18 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171289.php http://www.medicalnewstoday.com/articles/171289.php Top Institute Pharma (TI Pharma) has formed a consortium with Actelion Pharmaceuticals Ltd, Erasmus Medical Centre and Maastricht University to define new modalities for the treatment of hypertension (high blood pressure) and associated vascular complications such as heart and kidney failure, myocardial infarction and stroke. Hypertension Wed, 18 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171274.php http://www.medicalnewstoday.com/articles/171274.php Atrium Medical Corporation is proud to announce the release of the interim results from the COBEST clinical study. This study is to evaluate the use of bare metal stents vs. balloon expandable covered stents for the treatment of aorto-iliac occlusive disease. Prof. Patrice Mwipatayi of Royal Perth Hospital, Australia, presented interim data on the Covered versus Balloon Expandable Stent Trial known as COBEST at the 2009 VIVA (Vascular InterVentional Advances) meeting in Las Vegas. Vascular Wed, 18 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/171304.php http://www.medicalnewstoday.com/articles/171304.php An international team of scientists who took CT scans of mummified bodies of people who lived in Egypt up to 3,500 years ago found evidence to suggest that hardening of arteries, a risk factor for heart attacks and strokes, is not a modern disease and may have been quite common among ancient Egyptians of high socioeconomic status. Cardiovascular / Cardiology Tue, 17 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/171191.php http://www.medicalnewstoday.com/articles/171191.php Pulmonary embolism is a life-threatening condition most often caused by a blood clot breaking off from a vein and entering the circulatory system. While evidence-based guidelines exist to help physicians safely and efficiently evaluate patients with suspected pulmonary embolism, testing often differs from what is suggested. Researchers sought to determine if a computer program for use on a mobile, handheld device could improve diagnostic decision-making. Vascular Tue, 17 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/171130.php http://www.medicalnewstoday.com/articles/171130.php Researchers at Johns Hopkins are reporting what is believed to be the first conclusive evidence in men that the long-term ill effects of vitamin D deficiency are amplified by lower levels of the key sex hormone estrogen, but not testosterone. In a national study in 1010 men, to be presented Nov. Nutrition / Diet Mon, 16 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/171017.php http://www.medicalnewstoday.com/articles/171017.php NFL players and other athletes who suffer serious or multiple concussions may benefit from ground-breaking research being conducted by scientists at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center. The scientists are developing a surgical technique that involves hypothermia in specific regions of the brain. Therapeutic hypothermia is a medical treatment that lowers a patient's temperature in order to help reduce the risk of injury to tissue. Neurology / Neuroscience Thu, 12 Nov 2009 12:00:00 PST http://www.medicalnewstoday.com/articles/170775.php http://www.medicalnewstoday.com/articles/170775.php Nicast, developer of medical devices made of electrospun nanofabric, announced it is readying to launch the NovaMesh intra-abdominal hernia mesh in the European market in Q1 2010, pending European regulatory approval. NovaMesh is the first intra-abdominal hernia mesh to utilize the special properties of electrospun nanofabric. Vascular Thu, 12 Nov 2009 05:00:00 PST http://www.medicalnewstoday.com/articles/170760.php http://www.medicalnewstoday.com/articles/170760.php Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels. Inhibiting the formation of new blood vessels is an important aspect of, for example, cancer treatment. The study is published in the November issue of the journal Molecular Cancer Research. Vascular Thu, 12 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170673.php http://www.medicalnewstoday.com/articles/170673.php Catheter-directed therapy or catheter-directed thrombolysis--an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs--saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology. Respiratory / Asthma Wed, 11 Nov 2009 03:00:00 PST http://www.medicalnewstoday.com/articles/170539.php http://www.medicalnewstoday.com/articles/170539.php Use of erythropoiesis-stimulating agents is associated with an increased risk of venous thromboembolism, according to study published online November 10 in the Journal of the National Cancer Institute. Erythropoiesis-stimulating agents (i.e. Vascular Wed, 11 Nov 2009 02:00:00 PST http://www.medicalnewstoday.com/articles/170525.php http://www.medicalnewstoday.com/articles/170525.php Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. The findings will be published online on Nov. Cardiovascular / Cardiology Wed, 11 Nov 2009 00:00:00 PST http://www.medicalnewstoday.com/articles/170477.php http://www.medicalnewstoday.com/articles/170477.php The Vasculitis Center at Boston University School of Medicine (BUSM) has received a five-year $6 million grant from the National Institutes of Health. The grant will be used to research new biomarkers for vasculitis disease activity and prognosis. The research will also develop and standardize outcome measures for the different types of vasculitis, and develop and standardize imaging techniques for the large vessel vasculitides. Vascular Tue, 10 Nov 2009 06:00:00 PST http://www.medicalnewstoday.com/articles/170455.php http://www.medicalnewstoday.com/articles/170455.php Onset Medical Corporation announced today the Company has received U.S. FDA 510(k) marketing clearance for the Company's SoloPath™ TransFemoral Endovascular Access Catheter. Onset's SoloPath Endovascular Access Catheters are designed to provide access to diseased arteries at a relatively small catheter size and then be expanded to provide a conduit for the delivery of larger diameter devices. Vascular Mon, 09 Nov 2009 01:00:00 PST http://www.medicalnewstoday.com/articles/170257.php http://www.medicalnewstoday.com/articles/170257.php Vein Clinics of America (VCA) has announced its commitment of $150,000 to the American College of Phlebology Foundation (ACPF) over the next five years. All VCA physicians specialize in phlebology, the study of venous diseases and disorders. VCA, as one of the largest network of offices in the country dedicated to the minimally invasive treatment of vein disorders, announced the grant during the American College of Phlebology's Annual Congress in Palm Desert, Calif. Vascular Thu, 05 Nov 2009 04:00:00 PST http://www.medicalnewstoday.com/articles/169943.php http://www.medicalnewstoday.com/articles/169943.php Extended Therapy for Blood Clot Prevention Yields Greater Benefits in Hip/Knee Surgery (#8587) Patients undergoing total knee replacement (TKR) or total hip replacement (THR) surgeries may experience better outcomes if they receive extended therapy for the prevention of thrombosis (blood clots). Vascular Wed, 04 Nov 2009 21:00:00 PST http://www.medicalnewstoday.com/articles/169852.php http://www.medicalnewstoday.com/articles/169852.php Canadian physicians can now treat patients suffering from life-threatening aneurysms in one of the body's largest arteries with an endovascular graft delivered during a minimally invasive procedure without blocking a critical artery. Vascular